Photoprotection and 5-MOP photochemoprotection from UVR-induced DNA damage in humans: the role of skin type.

2.50
Hdl Handle:
http://hdl.handle.net/10541/104754
Title:
Photoprotection and 5-MOP photochemoprotection from UVR-induced DNA damage in humans: the role of skin type.
Authors:
Young, A R; Potten, Christopher S; Chadwick, Caroline A; Murphy, G M; Hawk, J L; Cohen, A J
Abstract:
Sites on previously unexposed buttock skin in 18 subjects (skin types I-V) were treated daily for 2 weeks with suberythemogenic doses of solar-simulated radiation (SSR) alone, SSR plus a UVB sunscreen, and SSR plus the same sunscreen with 5-methoxypsoralen at 30 ppm. The three sites of treatment (designated SSR, SSR/S, and SSR/S/5-MOP), and a control site that received no SSR or topical treatment, were challenged with 2MED SSR 1 week after the treatment had ceased. Biopsy samples, taken within 15 min after the challenge dose, were assessed for unscheduled DNA synthesis (UDS, interpreted as a measure of DNA damage), melanin deposition, and stratum corneum thickening. Within a given skin type, when compared with controls, the significant increase in either pigmentation or stratum corneum thickening was similar for SSR and SSR/S/5-MOP. SSR/S inhibited these endpoints. Compared with controls, UDS was significantly reduced in skin types III-V by SSR and in all skin types by SSR/S/5-MOP. SSR/S elicited no effect apart from minimal reductions in skin types IV and V. Thus, the increases in pigmentation and stratum corneum thickening seen in all skin types with SSR and SSR/S/5-MOP were accompanied by reduced UDS in all skin types with SSR/S/5-MOP but only in skin types III-V with SSR. These findings suggest that, although induced pigmentation and stratum corneum thickening may account in part for the reduction of UDS, qualitative differences in induced pigmentation may exist in skin types I-II between SSR and SSR/S/5-MOP treatments. The findings can also be interpreted to indicate that SSR/S/5-MOP treatment can afford protection against DNA damage from subsequent exposure to solar ultraviolet radiation. Risk-benefit considerations on the use of sunscreens with and without 5-MOP are discussed and the conclusion is drawn that the judicious use of 5-MOP sunscreens, particularly in skin types I-II, affords an alternative option to those seeking a suntan.
Affiliation:
Photobiology Department, United Medical School, Guy's Hospital, London, U.K.
Citation:
Photoprotection and 5-MOP photochemoprotection from UVR-induced DNA damage in humans: the role of skin type. 1991, 97 (5):942-8 J. Invest. Dermatol.
Journal:
Journal of Investigative Dermatology
Issue Date:
Nov-1991
URI:
http://hdl.handle.net/10541/104754
DOI:
10.1111/1523-1747.ep12491807
PubMed ID:
1919058
Type:
Article
Language:
en
ISSN:
0022-202X
Appears in Collections:
All Paterson Institute for Cancer Research

Full metadata record

DC FieldValue Language
dc.contributor.authorYoung, A Ren
dc.contributor.authorPotten, Christopher Sen
dc.contributor.authorChadwick, Caroline Aen
dc.contributor.authorMurphy, G Men
dc.contributor.authorHawk, J Len
dc.contributor.authorCohen, A Jen
dc.date.accessioned2010-06-11T15:36:52Z-
dc.date.available2010-06-11T15:36:52Z-
dc.date.issued1991-11-
dc.identifier.citationPhotoprotection and 5-MOP photochemoprotection from UVR-induced DNA damage in humans: the role of skin type. 1991, 97 (5):942-8 J. Invest. Dermatol.en
dc.identifier.issn0022-202X-
dc.identifier.pmid1919058-
dc.identifier.doi10.1111/1523-1747.ep12491807-
dc.identifier.urihttp://hdl.handle.net/10541/104754-
dc.description.abstractSites on previously unexposed buttock skin in 18 subjects (skin types I-V) were treated daily for 2 weeks with suberythemogenic doses of solar-simulated radiation (SSR) alone, SSR plus a UVB sunscreen, and SSR plus the same sunscreen with 5-methoxypsoralen at 30 ppm. The three sites of treatment (designated SSR, SSR/S, and SSR/S/5-MOP), and a control site that received no SSR or topical treatment, were challenged with 2MED SSR 1 week after the treatment had ceased. Biopsy samples, taken within 15 min after the challenge dose, were assessed for unscheduled DNA synthesis (UDS, interpreted as a measure of DNA damage), melanin deposition, and stratum corneum thickening. Within a given skin type, when compared with controls, the significant increase in either pigmentation or stratum corneum thickening was similar for SSR and SSR/S/5-MOP. SSR/S inhibited these endpoints. Compared with controls, UDS was significantly reduced in skin types III-V by SSR and in all skin types by SSR/S/5-MOP. SSR/S elicited no effect apart from minimal reductions in skin types IV and V. Thus, the increases in pigmentation and stratum corneum thickening seen in all skin types with SSR and SSR/S/5-MOP were accompanied by reduced UDS in all skin types with SSR/S/5-MOP but only in skin types III-V with SSR. These findings suggest that, although induced pigmentation and stratum corneum thickening may account in part for the reduction of UDS, qualitative differences in induced pigmentation may exist in skin types I-II between SSR and SSR/S/5-MOP treatments. The findings can also be interpreted to indicate that SSR/S/5-MOP treatment can afford protection against DNA damage from subsequent exposure to solar ultraviolet radiation. Risk-benefit considerations on the use of sunscreens with and without 5-MOP are discussed and the conclusion is drawn that the judicious use of 5-MOP sunscreens, particularly in skin types I-II, affords an alternative option to those seeking a suntan.en
dc.language.isoenen
dc.subject.meshDNA-
dc.subject.meshDNA Damage-
dc.subject.meshErythema-
dc.subject.meshFemale-
dc.subject.meshHumans-
dc.subject.meshMale-
dc.subject.meshMelanins-
dc.subject.meshPUVA Therapy-
dc.subject.meshSkin-
dc.subject.meshUltraviolet Rays-
dc.titlePhotoprotection and 5-MOP photochemoprotection from UVR-induced DNA damage in humans: the role of skin type.en
dc.typeArticleen
dc.contributor.departmentPhotobiology Department, United Medical School, Guy's Hospital, London, U.K.en
dc.identifier.journalJournal of Investigative Dermatologyen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.